Stock Scorer

Docebo Inc. (DCBO)

Docebo Inc. reported revenue of 57.3M USD for the quarter ending 31 March 2025, up 11.5% from 51.4M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q1 '25 · ending 31 March 2025 57.3M +11.5%
Gross Profit Q1 '25 · ending 31 March 2025 45.9M +10.7%
Operating Income Q1 '25 · ending 31 March 2025 1.7M -59.6%
Net Income Q1 '25 · ending 31 March 2025 1.5M -71.5%
Cost of Revenue Q1 '25 · ending 31 March 2025 11.4M +14.8%
Operating Cash Flow Q1 '25 · ending 31 March 2025 7.9M +27.8%
Free Cash Flow Q1 '25 · ending 31 March 2025 7.6M +25.5%
Shares Outstanding Q1 '25 · ending 31 March 2025 30.9M -6.7%
EPS Q1 '25 · ending 31 March 2025 0.74 +252.4%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 242.7M23.2M37.5M27.2M
20242024-12-31 216.9M21.3M26.7M28M
20232023-12-31 180.8M-3.7M2.8M15.3M
20222022-12-31 142.9M4.2M7M1.2M
20212021-12-31 104.2M-13.4M-13.6M-4.4M
20202020-12-31 62.9M-7.6M-8M3.7M
20192019-12-31 41.4M-9.8M-11.9M-4.9M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q1 '252025-03-3157.3M
Q4 '242024-12-3157M
Q3 '242024-09-3055.4M
Q2 '242024-06-3053.1M
Q1 '242024-03-3151.4M
Q4 '232023-12-3149.3M
Q3 '232023-09-3046.5M
Q2 '232023-06-3043.6M
Q1 '232023-03-3141.5M
Q4 '222022-12-3139M
Q3 '222022-09-3037M
Q2 '222022-06-3034.9M
Q1 '222022-03-3132.1M
Q4 '212021-12-3129.8M
Q3 '212021-09-3027.1M
Q2 '212021-06-3025.6M
Q1 '212021-03-3121.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q1 '252025-03-3145.9M
Q4 '242024-12-3146.4M
Q3 '242024-09-3045M
Q2 '242024-06-3042.8M
Q1 '242024-03-3141.5M
Q4 '232023-12-3140M
Q3 '232023-09-3037.7M
Q2 '232023-06-3035.2M
Q1 '232023-03-3133.4M
Q4 '222022-12-3131.4M
Q3 '222022-09-3029.8M
Q2 '222022-06-3028M
Q1 '222022-03-3125.5M
Q4 '212021-12-3123.7M
Q3 '212021-09-3021.4M
Q2 '212021-06-3020.5M
Q1 '212021-03-3117.9M

Operating Income Quarterly

PeriodEndingOperating Income
Q1 '252025-03-311.7M
Q4 '242024-12-317.8M
Q3 '242024-09-304.7M
Q2 '242024-06-304.5M
Q1 '242024-03-314.2M
Q4 '232023-12-311.1M
Q3 '232023-09-303.1M
Q2 '232023-06-30-7.5M
Q1 '232023-03-31-376K
Q4 '222022-12-31-75K
Q3 '222022-09-309M
Q2 '222022-06-302.1M
Q1 '222022-03-31-6.9M
Q4 '212021-12-31-2.9M
Q3 '212021-09-301.5M
Q2 '212021-06-30-6.3M
Q1 '212021-03-31-5.6M

Net Income Quarterly

PeriodEndingNet Income
Q1 '252025-03-311.5M
Q4 '242024-12-3111.9M
Q3 '242024-09-305M
Q2 '242024-06-304.7M
Q1 '242024-03-315.2M
Q4 '232023-12-313.2M
Q3 '232023-09-304M
Q2 '232023-06-30-5.7M
Q1 '232023-03-311.2M
Q4 '222022-12-311.6M
Q3 '222022-09-3010.3M
Q2 '222022-06-302.1M
Q1 '222022-03-31-7M
Q4 '212021-12-31-1.4M
Q3 '212021-09-30661K
Q2 '212021-06-30-7.2M
Q1 '212021-03-31-5.6M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q1 '252025-03-3111.4M
Q4 '242024-12-3110.7M
Q3 '242024-09-3010.5M
Q2 '242024-06-3010.3M
Q1 '242024-03-319.9M
Q4 '232023-12-319.3M
Q3 '232023-09-308.8M
Q2 '232023-06-308.4M
Q1 '232023-03-318.1M
Q4 '222022-12-317.5M
Q3 '222022-09-307.1M
Q2 '222022-06-307M
Q1 '222022-03-316.6M
Q4 '212021-12-316.1M
Q3 '212021-09-305.7M
Q2 '212021-06-305.2M
Q1 '212021-03-313.9M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q1 '252025-03-317.9M
Q4 '242024-12-319.7M
Q1 '242024-03-318.4M
Q4 '232023-12-316.5M
Q3 '232023-09-306.2M
Q2 '232023-06-305.5M
Q1 '232023-03-31-2.2M
Q4 '222022-12-312.2M
Q3 '222022-09-30975K
Q2 '222022-06-301.1M
Q1 '222022-03-31-2M
Q4 '212021-12-31-30K
Q3 '212021-09-30-410K
Q2 '212021-06-30-631K
Q1 '212021-03-31-2.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q1 '252025-03-317.6M
Q4 '242024-12-319.4M
Q1 '242024-03-318.2M
Q4 '232023-12-316.2M
Q3 '232023-09-306.1M
Q2 '232023-06-305.3M
Q1 '232023-03-31-2.3M
Q4 '222022-12-312M
Q3 '222022-09-30624K
Q2 '222022-06-30886K
Q1 '222022-03-31-2.3M
Q4 '212021-12-31-176K
Q3 '212021-09-30-1M
Q2 '212021-06-30-831K
Q1 '212021-03-31-2.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q1 '252025-03-3130.9M
Q3 '242024-09-3030.9M
Q1 '242024-03-3131M
Q3 '232023-09-3033.5M
Q2 '232023-06-3033.2M
Q1 '232023-03-3134.2M
Q3 '222022-09-3034.1M
Q2 '222022-06-3034M
Q1 '222022-03-3133M
Q3 '212021-09-3034.1M
Q2 '212021-06-3032.8M
Q1 '212021-03-3132.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '252025-03-310.74
Q4 '242024-12-310.86
Q3 '242024-09-300.57
Q2 '242024-06-300.53
Q1 '242024-03-310.21
Q4 '232023-12-310.08
Q3 '232023-09-300.04
Q2 '232023-06-300.22
Q1 '232023-03-310.45
Q4 '222022-12-310.20
Q3 '222022-09-30-0.63
Q2 '222022-06-30-0.91
Q1 '222022-03-31-1.19
Q4 '212021-12-31-1.15